DSM buys Kensey Nash for $360m to bump up biomaterials business
This article was originally published in Clinica
Executive Summary
Dutch sciences company Royal DSM is acquiring US regenerative medicine specialist Kensey Nash in a pivotal move that will turn the former's biomaterials unit into a profitable business.